mydrugindex
Kenyan Reference & Directory
Free lookups today: 0/3 · Unlimited with Pro Subscribe from KES 99
Free lookups: 0/3 Unlimited with Pro → Browse by class Interactions · Tip: type at least 2 letters, then pick a result
← New search | Chondroitin sulphate/sodium hyaluronate

INN monograph

Chondroitin sulphate/sodium hyaluronate

Therapeutic agent (verify pharmacological class) · POM

POM

Verified · Updated 01 Aug 2026 · Source: Local active-ingredient clinical extract; Professional class pharmacology (Therapeutic agent (verify pharmacological class))

Class
Therapeutic agent (verify pharmacolo...
Schedule
POM
Route
See product SmPC
Onset
Product-specific
Duration
Product-specific
Pregnancy
Use only if potential be...
Renal
Review renal impairment...
High-alert
No

Kenya market

Wholesale / list prices where loaded

From
Median
Brands
4

Risk first

Contraindications

  • [Chondroitin sulphate] Hypersensitivity to the active substance or excipients.
  • Additional absolute contraindications are indication- and product-specific — consult SmPC.

Precautions

  • Obtain allergy and medication history.
  • Adjust for renal/hepatic impairment, pregnancy, lactation, extremes of age and interacting drugs.
  • Use the lowest effective dose for the shortest appropriate duration.
  • Monitor for expected class adverse effects.

Point of care

Dosing

Adult

Dosing is indication-, age-, weight- and organ-function-specific for this INN. Do not use class averages for high-risk patients. Confirm the exact regimen in the current SmPC and Kenya Standard Treatment Guidelines. Typical professional workflow: (1) confirm indication, (2) check renal/hepatic function, (3) screen interactions/allergies, (4) select dose/route/duration, (5) define monitoring.

Paediatric

Paediatric dosing is weight- and age-based; use a paediatric formulary / SmPC. Do not extrapolate adult tablets without calculation.

Renal

Review renal impairment dosing; many agents need CrCl/eGFR adjustment.

  • CrCl 0–120: Confirm renal dosing in product SmPC / primary label.

Hepatic

Review hepatic impairment dosing; monitor LFTs if agent is hepatically cleared or hepatotoxic.

Safety

Drug interactions

Open checker →
  • Professional use: confirm indication, dose, duration, monitoring and patient counselling points against current Kenya STG / EML and the product SmPC.
  • Document allergy status and key interactions.

Safety

Adverse effects

  • Adverse reactions vary by agent.
  • Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes).
  • Report suspected ADRs via national pharmacovigilance channels.

Use

Indications

  • An eye surgical aid in cataract extraction and in intraocular lens implantation.
  • Clinical selection for Chondroitin sulphate/sodium hyaluronate should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC.
  • Class context: Therapeutic agent (verify pharmacological class).
  • Confirm site-specific dose, duration and monitoring before prescribing.

Pharmacology

Mode of action

It is a viscoelastic preparation that preserves a deep anterior chamber in the course of anterior segment surgery thus lowering the probability of trauma to the corneal endothelium and adjacent ocular tissues.

It is a viscoelastic preparation that pres…
Full mechanism text

It is a viscoelastic preparation that preserves a deep anterior chamber in the course of anterior segment surgery thus lowering the probability of trauma to the corneal endothelium and adjacent ocular tissues.

ADME

Pharmacokinetics & PD

Onset Product-specific
Duration Product-specific
Route See product SmPC
Elimination are product-specific. Consider food effects, protein binding, hepatic CYP/UGT
Half-life when adjusting for organ impairment, age and drug interactions. Verify parameters in the current SmPC.
Full PK/PD text

Absorption, distribution, metabolism and excretion are product-specific. Consider food effects, protein binding, hepatic CYP/UGT metabolism, renal clearance and half-life when adjusting for organ impairment, age and drug interactions. Verify parameters in the current SmPC.

Kenya

Brands & prices

4 listed
Brand Company Pack KES
Cartil (Collagen 150mg Glucosamine sulphate Potassium Chloride 500mg, Chondroitin sulphate sodium 100, Vitamin C 30mg, Cissus quadrangularis extract 300mg, Hyaluronic acid 25mg) Prism Life Sciences Standard Commercial Pack
Cartil Forte, [Glucosamine 500mg, Chondroitin Sulphate 200mg, Vit D3 200 i.u, Vit B12 10 mcg, Vit C 30 mg, Vit E 20 mg Folic acid 200 mcg, Zinc 7.5 mg, Manganese, Boron 1.5, Cu, 1 mg, Selenium 100 mcg Meyer Organics Standard Commercial Pack
Cartil Omega (Glucosamine 500mg, Chondroitin 200mg, Sodium hyaluronate 3mg, Omega 3 fish oil provides EPA 60 mg & DHA 40 mg Plus other vitamins & Minerals) Meyer Organics Standard Commercial Pack
Viscoat Alcon Pharmaceuticals Standard Commercial Pack

Special populations

Pregnancy & lactation

Pregnancy

Use only if potential benefit justifies potential risk; prefer agents with better reproductive data when alternatives exist.

Lactation

Assess infant risk vs benefit of maternal therapy; prefer agents with lactation data.

Diet

Food & alcohol

  • Food
  • Food

Trust

Sources & disclaimer

Source: Local active-ingredient clinical extract; Professional class pharmacology (Therapeutic agent (verify pharmacological class))

Last reviewed: 01 Aug 2026

Decision support only — not a substitute for clinical judgment, product SmPC, or Kenya STG/EML.

Kenya Verified Health Registry